Application Sponsors
Marketing Status
Application Products
001 | SOLUTION;ORAL | 100MG/ML | 0 | LEVETIRACETAM | LEVETIRACETAM |
FDA Submissions
| ORIG | 1 | AP | 2011-08-05 | |
LABELING; Labeling | SUPPL | 2 | AP | 2016-05-12 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2020-07-08 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2020-07-08 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2020-07-08 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2020-07-08 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 15 |
SUPPL | 3 | Null | 15 |
SUPPL | 4 | Null | 7 |
SUPPL | 5 | Null | 7 |
SUPPL | 6 | Null | 15 |
CDER Filings
APOTEX INC
cder:Array
(
[0] => Array
(
[ApplNo] => 90187
[companyName] => APOTEX INC
[docInserts] => ["",""]
[products] => [{"drugName":"LEVETIRACETAM","activeIngredients":"LEVETIRACETAM","strength":"100MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"LEVETIRACETAM","submission":"LEVETIRACETAM","actionType":"100MG\/ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)